Launch Costs—Spend Wisely: Pre-Launch and Post-Launch Analysis

Key Trends and Developments in the Chinese Oncology Market

ATTD 2020 – Transforming Diabetes Care Through Technology

Overcoming Challenges to Realize the Promise of Genetic Medicine

2019 Biopharma Year in Review

Australian Biotechs and Medtechs: Look to the East

Health Advances Presentation at AMCP Nexus: Costs of Mandating Blister Packaging for Opioids

Reflections on #Mesa19

Key Takeaways from ESMO 2019

The Cost of Launch

What’s Next in Anterior Segment Ophthalmic Care: Highlights from the 2019 ASCRS Annual Meeting

The Top 4 Attributes of a Successful Launch Plan

Orphan Drug Development – What are the Real Costs?

Keytruda, a case study for the improved regulatory environment in China

Improvements in China Drug Registration – Opening the Door to the China Market for Global BioPharma

Planning for Competition in Launch Strategy

Orphan Disease Drug Sales – How Much Opportunity is There by Region?

SHIFTING TIDES IN PHARMA DEALMAKING

Stakeholder Engagement Strategies in Launch Planning

The Year That Was: Oncology Edition

Health Advances Blog

Category: BioPharma

Launch Costs—Spend Wisely: Pre-Launch and Post-Launch Analysis

Key Trends and Developments in the Chinese Oncology Market

ATTD 2020 – Transforming Diabetes Care Through Technology

Overcoming Challenges to Realize the Promise of Genetic Medicine

2019 Biopharma Year in Review

Australian Biotechs and Medtechs: Look to the East

Health Advances Presentation at AMCP Nexus: Costs of Mandating Blister Packaging for Opioids

Reflections on #Mesa19

Key Takeaways from ESMO 2019

The Cost of Launch

What’s Next in Anterior Segment Ophthalmic Care: Highlights from the 2019 ASCRS Annual Meeting

The Top 4 Attributes of a Successful Launch Plan

Orphan Drug Development – What are the Real Costs?

Keytruda, a case study for the improved regulatory environment in China

Improvements in China Drug Registration – Opening the Door to the China Market for Global BioPharma

Planning for Competition in Launch Strategy

Orphan Disease Drug Sales – How Much Opportunity is There by Region?

SHIFTING TIDES IN PHARMA DEALMAKING

Stakeholder Engagement Strategies in Launch Planning

The Year That Was: Oncology Edition